RB1 and cancer: By this staging system, retinoblastoma patients may be placed in one of three genetic categories based on peripheral blood analysis: (1) those carrying a cancer-predisposing RB1 pathogenic variant (H1), (2) those with normal RB1 alleles (H0), and (3) those with an unknown or unexamined RB1 status (HX).